New technique for effective dose estimation using Monte Carlo simulation for the patients undergoing radioiodine therapy

被引:3
作者
Jokic, Vesna Spasic [1 ]
Kocovska, Marina Zdraveska [2 ]
机构
[1] Univ Novi Sad, Fac Tech Sci, Novi Sad 21000, Serbia
[2] Ss Cyril & Methodius Univ Skopje, Fac Med, Inst Pathophysiol & Nucl Med Akad Isak S Tadzer, Skopje 1000, Macedonia
关键词
Radioiodine; Radiotherapy; Beta particles; Effective dose; Monte Carlo code; THYROID-CANCER; DOSIMETRY;
D O I
10.1016/j.measurement.2012.09.019
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
We presume that radioiodine capsule, used for therapy, stays in stomach for 15 min before the absorption starts when large amount of radioactivity needlessly expose a part of stomach and several surrounding organs. Investigations were performed at Institute of Pathophysiology and Nuclear Medicine, Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Macedonia. Eighty-seven patients were reviewed, age between 21 and 73. Patients were divided in 20 groups receiving average dose per group from 1813 MBq to 6105 MBq. We used Monte Carlo MCNP 4b code and gave the results only for administrated activity of 6105 MBq. Calculated results are given for imparted energy per transformation, dose equivalent and effective doses for different organs. The effective doses were between 9.17 nSv (for bone surface) to 122.4 mSv (for stomach). As the total dose is estimated to be 126.73 mSv it is obvious that the highest part is received by stomach. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:795 / 802
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 2002, EV NUCL STRUCT DAT F
[2]  
[Anonymous], ANN ICRP
[3]  
[Anonymous], 1991, Annals of the ICRP, V21
[4]  
Behrens H., 1976, PHYS DATA 6 1
[5]  
Briesmeister J.F., 1977, LA12625M LOS AL NAT
[6]  
Chow S, 2005, Hong Kong J Radiol, V8, P127
[7]  
Chul S.Y.F., 1999, LUND LBNL NUCL DATA
[8]  
Eckerman K.F., 1996, ORNL MATH PHANTOM SE
[9]  
European Commission, 1998, 97 RP EUR COMM DIR G
[10]   CANCER RISKS IN THYROID-CANCER PATIENTS [J].
HALL, P ;
HOLM, LE ;
LUNDELL, G ;
BJELKENGREN, G ;
LARSSON, LG ;
LINDBERG, S ;
TENNVALL, J ;
WICKLUND, H ;
BOICE, JD .
BRITISH JOURNAL OF CANCER, 1991, 64 (01) :159-163